Hagino T, Saeki H, Fujimoto E, Kanda N, et al. Effectiveness of Tralokinumab for Upadacitinib-Refractory Atopic Dermatitis: 48-week Retrospective Study. J Am Acad Dermatol 2025 Jul 19:S0190-9622(25)02528.
PMID: 40692046